1. Pink Sheet
  2. >>Geography
  3. >>Europe
  4. >>United Kingdom

UK Pips EU To The Post With ‘Project Orbis’ Approval For Tagrisso

EU Early-Use Approval For AstraZeneca’s NSCLC Drug Imminent

 
• By Neena Brizmohun

The UK drug regulator, the MHRA, has approved its first product under Project Orbis, the US-led international regulatory collaboration scheme it joined four months ago to speed up access to promising cancer medicines.

Double Exposure Team Teamwork Togetherness Collaboration Concept
Regulatory collaboration is expected to help speed up drug approvals • Source: Alamy

Tagrisso (osimertinib), AstraZeneca’s lung cancer treatment, has become the first product to be approved by the UK medicines regulator under Project Orbis, the US-led scheme that enables international regulators to simultaneously review new cancer drugs and approve them faster.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

More from Europe